Literature DB >> 15550149

ADULT ectodermal dysplasia syndrome resulting from the missense mutation R298Q in the p63 gene.

I Chan1, J I Harper, J E Mellerio, J A McGrath.   

Abstract

Several ectodermal dysplasia syndromes have been shown to result from mutations in the gene that encodes the transcription factor p63. We describe an 11-year-old boy, with clinically normal parents, who had a developmental disorder that resembled EEC (ectrodactyly ectodermal dysplasia-clefting) syndrome (OMIM 604292). He had ectrodactyly and missing middle fingers bilaterally, onychodysplasia, hypodontia with missing teeth, hypohidrosis and lacrimal duct obstruction. DNA sequencing disclosed a heterozygous G-->A substitution at nucleotide 893, that converts an arginine residue (CGA) to glutamine (CAA), the mutation being designated R298Q. This mutation occurs within the DNA-binding domain of p63, and is close to many of the published EEC syndrome mutations. However, R298Q has been described once previously in a large German pedigree, not with EEC syndrome, but another ectodermal dysplasia disorder, ADULT (acro-dermato-ungual-lacrimal-tooth) syndrome (OMIM 103285). Further clinical assessment in our patient revealed that, apart from not having cleft lip and/or palate, he had an exfoliative dermatitis of his hands and feet, and some freckling on his face and shoulders. Collectively, these features support a diagnosis of ADULT syndrome. This study has identified a specific genotype-phenotype correlation in a rare ectodermal dysplasia syndrome and the findings are useful in improving genetic counselling in this family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550149     DOI: 10.1111/j.1365-2230.2004.01643.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  Severe persistent nasolacrimal duct obstruction: a typical finding in ADULT syndrome.

Authors:  N Eter; K Zerres; P Propping; P Roggenkämper; M Spitznas
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

2.  ADULT Phenotype and rs16864880 in the TP63 Gene: Two New Cases and Review of the Literature.

Authors:  Tânia Kawasaki de Araujo; Elaine Lustosa-Mendes; Ana P Dos Santos; Miriam Coelho Molck; Roberta Mazzariol Volpe-Aquino; Vera L Gil-da-Silva-Lopes
Journal:  Mol Syndromol       Date:  2017-04-13

3.  p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Authors:  Rubeta N Matin; Anissa Chikh; Stephanie Law Pak Chong; David Mesher; Manuela Graf; Paolo Sanza'; Valentina Senatore; Maria Scatolini; Francesca Moretti; Irene M Leigh; Charlotte M Proby; Antonio Costanzo; Giovanna Chiorino; Rino Cerio; Catherine A Harwood; Daniele Bergamaschi
Journal:  J Exp Med       Date:  2013-02-18       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.